GABELLI & Co INVESTMENT ADVISERS INC. bought a new position in CAS Medical Systems Inc (NASDAQ:CASM) during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 25,000 shares of the medical technology company’s stock, valued at approximately $61,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc boosted its stake in shares of CAS Medical Systems by 2.8% in the 3rd quarter. Vanguard Group Inc now owns 547,560 shares of the medical technology company’s stock worth $1,249,000 after buying an additional 15,155 shares during the last quarter. Virtu Financial LLC purchased a new position in shares of CAS Medical Systems in the 1st quarter worth approximately $42,000. Harvest Management LLC purchased a new position in shares of CAS Medical Systems in the 1st quarter worth approximately $76,000. Douglas Lane & Associates LLC purchased a new position in shares of CAS Medical Systems in the 4th quarter worth approximately $54,000. Finally, Renaissance Technologies LLC boosted its stake in shares of CAS Medical Systems by 76.4% in the 3rd quarter. Renaissance Technologies LLC now owns 682,017 shares of the medical technology company’s stock worth $1,555,000 after buying an additional 295,478 shares during the last quarter. Hedge funds and other institutional investors own 27.61% of the company’s stock.
CAS Medical Systems stock opened at $2.45 on Thursday. CAS Medical Systems Inc has a 12 month low of $1.06 and a 12 month high of $2.70. The company has a market capitalization of $71.88 million, a P/E ratio of -9.07 and a beta of 0.51.
Separately, Craig Hallum downgraded CAS Medical Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, February 12th.
COPYRIGHT VIOLATION NOTICE: “GABELLI & Co INVESTMENT ADVISERS INC. Buys New Position in CAS Medical Systems Inc (CASM)” was first posted by Equities Focus and is owned by of Equities Focus. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.equitiesfocus.com/2019/05/09/gabelli-co-investment-advisers-inc-buys-new-position-in-cas-medical-systems-inc-casm.html.
CAS Medical Systems Profile
CAS Medical Systems, Inc, a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations.
See Also: What is Cost of Goods Sold (COGS)?
Want to see what other hedge funds are holding CASM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CAS Medical Systems Inc (NASDAQ:CASM).
Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.